title: HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.
abstract: HIV-1 Envelope (Env) protein is the sole target of neutralizing antibodies (NAbs) that arise during infection to neutralize autologous variants. Under this immune pressure, HIV escape variants are continuously selected and over the course of infection Env becomes more neutralization resistant. Many common alterations are known to affect sensitivity to NAbs, including residues encoding potential N-linked glycosylation sites (PNGS). Knowledge of Env motifs associated with neutralization resistance is valuable for the design of an effective Env-based vaccine so we characterized Envs isolated longitudinally from a SHIV(SF162P4) infected macaque for sensitivity to neutralizing monoclonal antibodies (MAbs) B12, 2G12, 4E10 and 2F5. The early Env, isolated from plasma at day 56 after infection, was the most sensitive and the late Env, from day 670, was the most resistant to MAbs. We identified four PNGS in these Envs that accumulated over time at positions 130, 139, 160 and 397. We determined that removal of these PNGS significantly increased neutralization sensitivity to 2G12, and conversely, we identified mutations by in silico analyses that contributed resistance to 2G12 neutralization. In order to expand our understanding of these PNGS, we analyzed Envs from clade B HIV-infected human subjects and identified additional glycan and amino acid changes that could affect neutralization by 2G12 in a context-dependent manner. Taken together, these in vitro and in silico analyses of clade B Envs revealed that 2G12 resistance is achieved by previously unrecognized PNGS substitutions in a context-dependent manner and by subject-specific pathways.
authors.affiliation: Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
authors.forename: Delphine C
authors.initials: DC
authors.lastname: Malherbe
authors.forename: Rogier W
authors.initials: RW
authors.lastname: Sanders
authors.forename: Marit J
authors.initials: MJ
authors.lastname: van Gils
authors.forename: Byung
authors.initials: B
authors.lastname: Park
authors.forename: Michelle M
authors.initials: MM
authors.lastname: Gomes
authors.forename: Hanneke
authors.initials: H
authors.lastname: Schuitemaker
authors.forename: Susan
authors.initials: S
authors.lastname: Barnett
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Haigwood
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D057134:Antibodies, Neutralizing / Q000276:immunology*; D001665:Binding Sites; D000080908:Broadly Neutralizing Antibodies; D019295:Computational Biology; D006031:Glycosylation; D015483:HIV Antibodies; D015497:HIV-1; D006801:Humans; D008251:Macaca; D008958:Models, Molecular; D009154:Mutation; D011487:Protein Conformation; D054299:env Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000378:metabolism
chemical_list: C529157:2G12 monoclonal antibody; D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D000080908:Broadly Neutralizing Antibodies; D015483:HIV Antibodies; D054299:env Gene Products, Human Immunodeficiency Virus
references.citation: J Virol. 1996 Feb;70(2):1100-8
references.pmid: 8551569
references.citation: Science. 2003 Jun 27;300(5628):2065-71
references.pmid: 12829775
references.citation: Science. 2004 Mar 26;303(5666):2019-22
references.pmid: 15044802
references.citation: J Virol. 2010 Nov;84(21):11200-9
references.pmid: 20702624
references.citation: Nature. 1998 Jun 18;393(6686):648-59
references.pmid: 9641677
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):14943-8
references.pmid: 16219699
references.citation: Bioinformatics. 2006 Jan 15;22(2):195-201
references.pmid: 16301204
references.citation: J Virol. 2010 Sep;84(18):9608-12
references.pmid: 20610714
references.citation: J Virol. 1993 Dec;67(12):7493-500
references.pmid: 7693973
references.citation: Nature. 2011 Sep 22;477(7365):466-70
references.pmid: 21849977
references.citation: J Virol. 2011 Jun;85(11):5262-74
references.pmid: 21430056
references.citation: J Virol. 2007 Dec;81(23):13037-49
references.pmid: 17855534
references.citation: Virology. 2007 Aug 1;364(2):441-53
references.pmid: 17418361
references.citation: J Virol. 2005 Jan;79(2):1252-61
references.pmid: 15613352
references.citation: J Virol. 2005 May;79(10):6528-31
references.pmid: 15858037
references.citation: J Virol. 2003 May;77(10):5863-76
references.pmid: 12719580
references.citation: PLoS Pathog. 2009 Sep;5(9):e1000598
references.pmid: 19763271
references.citation: J Virol. 2007 Oct;81(19):10769-76
references.pmid: 17634239
references.citation: Electrophoresis. 1997 Dec;18(15):2714-23
references.pmid: 9504803
references.citation: J Virol. 2006 Jan;80(2):999-1014
references.pmid: 16379001
references.citation: Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
references.pmid: 12019106
references.citation: Nature. 2002 Dec 12;420(6916):678-82
references.pmid: 12478295
references.citation: J Virol. 2003 Jan;77(1):642-58
references.pmid: 12477867
references.citation: J Virol. 2007 Aug;81(16):8533-42
references.pmid: 17522228
references.citation: Science. 2011 Nov 25;334(6059):1097-103
references.pmid: 21998254
references.citation: J Virol. 2009 Jan;83(2):757-69
references.pmid: 18987148
references.citation: J Virol. 2009 Jan;83(2):662-72
references.pmid: 18987151
references.citation: J Virol. 2010 Apr;84(7):3576-85
references.pmid: 20071586
references.citation: Immunology. 1991 Aug;73(4):371-6
references.pmid: 1916888
references.citation: J Virol. 2002 Jul;76(14):7293-305
references.pmid: 12072528
references.citation: J Virol. 2002 Jul;76(14):7306-21
references.pmid: 12072529
references.citation: J Infect Dis. 2010 Apr 1;201(7):1045-53
references.pmid: 20170371
references.citation: J Virol. 2004 Dec;78(23):13232-52
references.pmid: 15542675
references.citation: J Virol. 2002 Oct;76(20):10299-306
references.pmid: 12239306
references.citation: J Virol. 1994 Nov;68(11):6994-7000
references.pmid: 7933081
references.citation: Retrovirology. 2008 Jan 31;5:10
references.pmid: 18237398
references.citation: Science. 2009 Oct 9;326(5950):285-9
references.pmid: 19729618
references.citation: J Virol. 2008 Jun;82(12):5807-14
references.pmid: 18385254
references.citation: AIDS. 2005 Nov 18;19(17):1957-66
references.pmid: 16260901
references.citation: J Virol. 2007 Jun;81(12):6402-11
references.pmid: 17392364
references.citation: J Mol Biol. 1998 Apr 17;277(5):1141-52
references.pmid: 9571028
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3381-5
references.pmid: 12824332
references.citation: J Virol. 2004 Apr;78(7):3279-95
references.pmid: 15016849
references.citation: J Virol. 2008 Feb;82(3):1591-9
references.pmid: 18032508
references.citation: Adv Exp Med Biol. 2003;535:205-18
references.pmid: 14714897
references.citation: PLoS Med. 2008 Jan 3;5(1):e9
references.pmid: 18177204
references.citation: Virology. 2009 Aug 1;390(2):348-55
references.pmid: 19539340
references.citation: BioDrugs. 2009;23(3):137-53
references.pmid: 19627166
references.citation: Nature. 2003 Mar 20;422(6929):307-12
references.pmid: 12646921
references.citation: PLoS Pathog. 2009 Sep;5(9):e1000594
references.pmid: 19763269
references.citation: Virology. 2003 Sep 1;313(2):387-400
references.pmid: 12954207
references.citation: J Virol. 1997 Oct;71(10):7719-27
references.pmid: 9311856
references.citation: J Virol. 2011 Apr;85(7):3642-8
references.pmid: 21248038
references.citation: Science. 2005 Nov 11;310(5750):1025-8
references.pmid: 16284180
references.citation: Virology. 2012 Apr 25;426(1):34-41
references.pmid: 22314018
references.citation: Br Med Bull. 2001;58:19-42
references.pmid: 11714622
references.citation: J Virol. 1996 Dec;70(12):8431-7
references.pmid: 8970964
references.citation: J Virol. 2006 Oct;80(19):9586-98
references.pmid: 16973562
references.citation: PLoS Comput Biol. 2010 Oct 07;6(10):e1000955
references.pmid: 20949103